A significant shift in the country's drug policy has taken place, as the regulators permit the availability of psilocybin hallucinogens for therapeutic applications. Before this, these substances were heavily restricted, but a growing body of evidence suggests they may offer aid for emotional illnesses like PTSD. This change represents a key step t